ReviewMaterials today. Bio2026
Grafts in tendon repair.
Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inferior healing after tendon rupture often necessitates the use of grafts to reinforce tendon repair and promote the regeneration of functional tissue. Autograft or allograft implantations are considered the gold standard in tendon reconstruction, though these types of treatment may not always be feasible due to limited availability and patient-specific considerations. In such cases, commercial tendon grafts, encompassing bridging and augmenting grafts are preferred but may not always lead to optimal healing. Consequently, research into the development of more effective constructs for tendon repair is constantly evolving. Here, we review progress in the field by considering the structure and biology of tendons as well as the natural tendon healing processes that inform the evolution of tissue engineered tendon grafts. The limitations of commercial tendon constructs are outlined to establish the opportunities presented by a range of structures, materials, and bioactive adjuncts currently being engineered into tendon grafts to improve tendon recovery and regeneration. We present
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.